Skip to main content
Meta navigation
Contact
Donate
Jobs
Main navigation
For patients
For researchers
About us
Network
Leukemia
2 currently open clinical trials
Treatment with ivosidenib or enasidenib for patients with mutations in enzymes (IDH1 or IDH2 mutation)
HOVON 150
Chemotherapy augmented by gilteritinib or midostaurin in patients with acute myeloid leukemia
HOVON 156
All cancer types
Mobile main navigation
For patients
For patients
Participate in a trial
Genetic Counseling
FAQ
Glossary
Downloads
For researchers
For researchers
Research groups
Young Oncology Academy
Grants and fellowships
Electronic Data Capture (EDC)
About us
About us
Mission statement
Organization
Board
Scientific Committee
Directors' Committee
Executive Committee and Extended Executive Committee
Patient Advisory Board
Support and collaborations
Media and publications
Network
Mobile meta navigation
Contact
Donate
Jobs
Vacancies
Work for us
Our values
Work–life balance
Wages and benefits
Staff development
Mobile footer navigation
Imprint
Privacy Policy
Disclaimer
EN
DE
FR
Mobile quicklinks
Trials
Events
News
Portal
Quicklinks
Trials
Events
News
Portal
